# 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis

> **NCT01587898** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 72 (actual)

## Conditions studied

- Anaemia

## Interventions

- **DRUG:** GSK1278863
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01587898
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-17
- **Primary completion:** 2013-05-07
- **Final completion:** 2013-05-07
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587898, "4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01587898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
